Idexx Laboratories (IDXX)
Idexx Laboratories stock today
Idexx Laboratories closed at $551.21 on October 30, 2026, down 4.30% on the day. Over the past year it returned -12.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $43.5 billion.
| Period | IDXX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +5.6% | -0.9% |
| 3 months | -1.4% | +2.1% |
| Year to date | -18.5% | +11.7% |
| 1 year | -12.3% | +12.4% |
| 3 years | +39.1% | +88.5% |
| 5 years | -17.3% | +76.0% |
Key statistics
- Market value
- $43.5B
- P/E (trailing)
- 38.7
- Forward P/E
- 34.9
- Price / sales
- 9.6
- 52-week range
- $504.70 to $766.68
- Next report
- Nov 2, 2026
About Idexx Laboratories
Develops and sells diagnostic products and software for veterinary and animal health.
Sector: Health Care · Industry: Health Care Equipment
More on Idexx Laboratories
- Financials: revenue, earnings and segmentsRevenue +10% in the year to Dec 2025
- Valuation: P/E history and peersP/E 38.7, median 52.5 at its last 10 year ends
- Returns: what $1,000 became$1,000 ten years ago is $5,247 today
No forecast, no recommendation. This page describes Idexx Laboratories from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.